Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1053/j.semperi.2013.01.009 http://scihub22266oqcxt.onion/10.1053/j.semperi.2013.01.009 C4464837!4464837!23582967     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Semin+Perinatol 2013 ; 37 (2): 124-31 Nephropedia Template TP {{tp|p=23582967|t=2013. Pulmonary Hypertension in Bronchopulmonary Dysplasia |pdf=|usr=}}{{23582967}} gab.com Text Pulmonary Hypertension in Bronchopulmonary Dysplasia JO: Semin Perinatol http://www.kidney.de/pget.php?&tw=1&pmid=23582967 #FOAvip Pulmonary hypertension (PH) is a common complication of neonatal respiratory diseases including bronchopulmonary dysplasia (BPD), and recent studies have increased awareness that PH worsens the clinical course, morbidity and mortality of BPD. Recent evidence indicates that up to 18% of all extremely low birth weight infants will develop some degree of PH during their hospitalization, and the incidence rises to 25?40% of infants with established BPD. Risk factors are not yet well understood, but new evidence shows that fetal growth restriction is a significant predictor of PH. Echocardiography remains the primary method for evaluation for BPD-associated PH, and the development of standardized screening timelines and techniques for identification of infants with BPD-associated PH remains an important ongoing topic of investigation. The use of pulmonary vasodilator medications such as nitric oxide, sildenafil, and others in the BPD population is steadily growing, but additional studies are needed regarding their long-term safety and efficacy. Twit Text FOAVip Pulmonary Hypertension in Bronchopulmonary Dysplasia ????Semin Perinatol http://www.kidney.de/pget.php?&tw=1&pmid=23582967 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=23582967 #FOAvip English Wikipedia <ref>{{Cite pmid|23582967}}</ref> Pulmonary Hypertension in Bronchopulmonary Dysplasia #MMPMID23582967 Berkelhamer SK; Mestan KK; Steinhorn RH Semin Perinatol 2013[Apr]; 37 (2): 124-31 PMID23582967show ga Pulmonary hypertension (PH) is a common complication of neonatal respiratory diseases including bronchopulmonary dysplasia (BPD), and recent studies have increased awareness that PH worsens the clinical course, morbidity and mortality of BPD. Recent evidence indicates that up to 18% of all extremely low birth weight infants will develop some degree of PH during their hospitalization, and the incidence rises to 25?40% of infants with established BPD. Risk factors are not yet well understood, but new evidence shows that fetal growth restriction is a significant predictor of PH. Echocardiography remains the primary method for evaluation for BPD-associated PH, and the development of standardized screening timelines and techniques for identification of infants with BPD-associated PH remains an important ongoing topic of investigation. The use of pulmonary vasodilator medications such as nitric oxide, sildenafil, and others in the BPD population is steadily growing, but additional studies are needed regarding their long-term safety and efficacy. äPulmonary Hypertension in Bronchopulmonary Dysplasia (epmc).pdf DeepDyve Pubget Overpricing